Literature DB >> 7998960

Divalent cations stabilize the conformation of plasma cell membrane glycoprotein PC-1 (alkaline phosphodiesterase I).

S I Belli1, A Sali, J W Goding.   

Abstract

The plasma cell-membrane glycoprotein PC-1 is an ectoenzyme with alkaline phosphodiesterase I/5'-nucleotide phosphodiesterase (EC 3.1.4.1) and nucleotide pyrophosphatase (EC 3.6.1.9) activities. It contains sequence motifs which closely match the consensus EF-hand (helix-loop-helix) Ca(2+)-binding regions of parvalbumin, troponin-C and calmodulin, and its enzymic activity is increased in the presence of divalent cations and decreased in the presence of chelating agents. We have undertaken experiments to determine whether divalent cations affect the conformation of the PC-1 protein, as assessed by their effect on thermal stability, resistance to proteolysis and binding of polyclonal antibodies to the whole native protein and monoclonal antibodies to a putative Ca(2+)-binding region. Divalent cations were found to protect solubilized PC-1 against thermal denaturation and proteolysis. They also stabilized PC-1 on intact cells; this form was much more resistant to proteolysis than Triton X-100 solubilized PC-1. Ca2+, Mg2+ and Zn2+ ions were equally effective. Monoclonal antibodies to the bacterially expressed C-terminal EF-hand homology region only bound to mammalian PC-1 in the absence of Ca2+. In contrast, the great majority of polyclonal antibodies to native PC-1 bound regardless of whether Ca2+ was present or not, but with increased binding when Ca2+ was present. These results provide evidence that divalent cations bind to PC-1 and stabilize its conformation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998960      PMCID: PMC1137454          DOI: 10.1042/bj3040075

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  New vectors for high level expression of recombinant proteins in bacteria.

Authors:  D J Hakes; J E Dixon
Journal:  Anal Biochem       Date:  1992-05-01       Impact factor: 3.365

2.  5'-Nucleotide phosphodiesterase: isolation of covalently bound 5'-adenosine monophosphate, an intermediate in the catalytic mechanism.

Authors:  M Landt; L G Butler
Journal:  Biochemistry       Date:  1978-10-03       Impact factor: 3.162

3.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

4.  Structure of the murine plasma cell alloantigen PC-1: comparison with the receptor for transferrin.

Authors:  J W Goding; F W Shen
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  The murine plasma cell antigen PC-1: purification and partial amino acid sequence.

Authors:  P A Stearne; I R van Driel; B Grego; R J Simpson; J W Goding
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

6.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

7.  The amino-acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins.

Authors:  T Isobe; T Okuyama
Journal:  Eur J Biochem       Date:  1978-09-01

8.  Structure of vitamin D-dependent calcium-binding protein from bovine intestine.

Authors:  D M Szebenyi; S K Obendorf; K Moffat
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

9.  Plasma cell membrane glycoprotein PC-1. Primary structure deduced from cDNA clones.

Authors:  I R van Driel; J W Goding
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

10.  Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase).

Authors:  S I Belli; I R van Driel; J W Goding
Journal:  Eur J Biochem       Date:  1993-10-01
View more
  8 in total

1.  A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases.

Authors:  M Y Galperin; A Bairoch; E V Koonin
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

Review 2.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

3.  Characterization of a new plasma membrane-associated ecto-5'-phosphodiesterase/nucleotide-pyrophosphatase from rat hepatocarcinoma AS-30D cells.

Authors:  R M García-Nieto; E S José; J Martín-Nieto; A Villalobo
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

4.  Thermal analysis of the plasma membrane Ca2+-ATPase.

Authors:  J Santiago-García; B A Delgado-Coello; J Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

5.  Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes.

Authors:  M Lotz; F Rosen; G McCabe; J Quach; F Blanco; J Dudler; J Solan; J Goding; J E Seegmiller; R Terkeltaub
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 6.  Autotaxin.

Authors:  Jean A Boutin; Gilles Ferry
Journal:  Cell Mol Life Sci       Date:  2009-06-09       Impact factor: 9.261

7.  CD38 binding to human myeloid cells is mediated by mouse and human CD31.

Authors:  A L Horenstein; H Stockinger; B A Imhof; F Malavasi
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

8.  Understanding the enzymatic inhibition of intestinal alkaline phosphatase by aminophenazone-derived aryl thioureas with aided computational molecular dynamics simulations: synthesis, characterization, SAR and kinetic profiling.

Authors:  Asma Khurshid; Aamer Saeed; Zaman Ashraf; Qamar Abbas; Mubashir Hassan
Journal:  Mol Divers       Date:  2020-08-29       Impact factor: 2.943

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.